Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2
about
Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha.Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptorInterleukin-12 induces interferon-gamma expression and natural killer cytotoxicity in cord blood mononuclear cells.Combination of cytokines: current status and future prospects.Tumour necrosis factor: a cytokine with multiple biological activities.Tumor necrosis factor and human acute leukemia.Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.Peripheral blood mononuclear cells from house dust mite allergic patients produce IL-2 in response to specific allergen challenge.Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha.Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.Development of a serum-free medium for a human immortalized fibroblast cell line (KMST-6/TNF) producing tumor necrosis factor-alpha (TNF-alpha) and growth inhibitory effects of its conditioned medium on malignant cells in culture.Effects of interleukin-1 alpha and cyclosporin A in vivo and in vitro on bone and lymphoid tissues in mice.Augmentation of murine lymphokine-activated killer cell induction by a factor produced by Nocardia rubra cell wall skeleton-stimulated T cells.Synergy of Nocardia rubra cell wall skeleton and interleukin 2 in the in vivo induction of murine lymphokine-activated killer cell activity.
P2860
Q33771233-51555842-FED7-46A3-8596-26D192DA0F89Q33804742-74B5A0B9-1EBA-4EC6-B08A-88670A58B223Q34253470-6DED292C-7095-4863-BFDE-EEF99022D857Q36080342-FBBE17FF-0CAD-45ED-A561-2148800597A2Q36821903-71C64865-1F1E-449D-8776-F3E47B16B082Q37422360-A55ED4A1-940E-41E9-9060-6B86C6E6B7CDQ37916679-8719373A-D423-4888-B54C-89E2F99924F0Q40388344-F985073B-2C50-470D-80DD-53F0957804E7Q41482163-F6220742-774C-4942-A954-0432F990FE97Q41574947-D8245583-DDC1-4E9D-B65A-185DC555BAE2Q41988723-95C64B91-7A6F-4537-A86F-F000576D9E42Q42057633-AAA8D8A6-2342-4BCF-B6CB-9DE0AE5AD2D4Q43615985-0533B735-EC77-4174-882C-012861512D66Q43653025-C4A9F3BE-0367-4A58-B406-3739D44DB933Q55024463-64A4D776-25C3-49B6-B46C-BB288B4E3953Q55381623-E8CD3C65-3307-4E51-9EC4-9CC25443B6D2
P2860
Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2
description
1988 nî lūn-bûn
@nan
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Generation of lymphokine-activ ...... rosis factor and interleukin 2
@ast
Generation of lymphokine-activ ...... rosis factor and interleukin 2
@en
type
label
Generation of lymphokine-activ ...... rosis factor and interleukin 2
@ast
Generation of lymphokine-activ ...... rosis factor and interleukin 2
@en
prefLabel
Generation of lymphokine-activ ...... rosis factor and interleukin 2
@ast
Generation of lymphokine-activ ...... rosis factor and interleukin 2
@en
P2093
P2860
P356
P1476
Generation of lymphokine-activ ...... rosis factor and interleukin 2
@en
P2093
D Fradelizi
J Bertoglio
P2860
P304
P356
10.1073/PNAS.85.18.6875
P407
P577
1988-09-01T00:00:00Z